Skip to main content
OFIX
NASDAQ Industrial Applications And Services

Orthofix Realigns Spine Leadership, Reports Preliminary Q1 Sales, Reaffirms 2026 Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$12.23
Mkt Cap
$489.762M
52W Low
$10.24
52W High
$16.99
52W Position info
19% above low
Off High info
28% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

OFIX sits 19% above its 52-week low of $10.24.

Summary

Orthofix announced a strategic realignment of its Spine leadership, including the departure of the President, Global Spine, while also reporting preliminary Q1 2026 net sales and reaffirming its full-year 2026 financial guidance.


Key Events · Executive and Board Changes · OFIX

  • Spine Leadership Realignment

    Max Reinhardt, President, Global Spine, will be departing on or about June 12, 2026, as part of a strategic move to streamline the Spine organization. Key Spine leaders will now report directly to the CEO.

  • Preliminary Q1 2026 Net Sales

    The company reported preliminary, unaudited net sales of approximately $196.7 million for the first quarter ended March 31, 2026, representing a 0.4% increase on a reported basis and 3% on a non-GAAP pro forma constant currency basis compared to Q1 2025.

  • 2026 Guidance Reaffirmed

    Orthofix reaffirmed its full-year 2026 guidance, expecting net sales between $850 million to $860 million, non-GAAP adjusted EBITDA of $95 million to $98 million, and positive free cash flow.


Analysis · OFIX · Industrial Applications And Services

This 8-K details significant operational and leadership changes at Orthofix, following a challenging 2025 marked by a substantial net loss. The departure of the President, Global Spine, as part of a strategic realignment, aims to streamline decision-making and accelerate growth, indicating a proactive effort to address past performance issues. Concurrently, the company's preliminary Q1 sales, while showing modest growth, coupled with the reaffirmation of its full-year 2026 guidance for sales, adjusted EBITDA, and positive free cash flow, provides a crucial update on its financial trajectory. This suggests management is confident in its ability to execute its turnaround plan and achieve its stated financial targets, offering a degree of stability and a path forward for investors.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, OFIX was trading at $12.23 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $489.8M. The 52-week trading range was $10.24 to $16.99. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OFIX - Latest Insights

OFIX
Nov 12, 2026, 6:08 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $7.01
Real-time Price: $6.52 info
Change: -$0.490 (-7%) info
Market Cap: $265.754M info
OFIX
Nov 12, 2026, 5:39 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $6.94
Real-time Price: $6.52 info
Change: -$0.420 (-6%) info
Market Cap: $265.754M info
OFIX
Nov 09, 2026, 8:02 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $6.65
Real-time Price: $6.52 info
Change: -$0.130 (-2%) info
Market Cap: $265.754M info
OFIX
Nov 09, 2026, 8:01 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.65
Real-time Price: $6.52 info
Change: -$0.130 (-2%) info
Market Cap: $265.754M info
OFIX
Nov 09, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $7.09
Real-time Price: $6.52 info
Change: -$0.5707 (-8%) info
Market Cap: $265.754M info